Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

milodistim

A recombinant fusion protein derived from the coding sequences of two growth factors, interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF). Milodistim exhibits greater receptor binding affinity and colony stimulating activity than its parent cytokines. This agent stimulates proliferation of immature hematopoietic cells and allows the stimulation and expansion of multi-lineage hematopoiesis from immature bone marrow progenitor cells.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	GM-CSF/IL-3 Fusion Protein GM-CSF/IL3 Fusion Protein Granulocyte-Macrophage Colony Stimulating Factor/Interleukin-3 Fusion Protein pixykine
Code name:	PIXY321
IND number:	4341
NSC code:	645014

milodistim

Search NCI's Drug Dictionary